Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Common Stock | Options Exercise | $127K | +2K | +5.37% | $63.55 | 39.2K | Nov 5, 2021 | Direct | |
transaction | XYL | Common Stock | Sale | -$261K | -2K | -5.1% | $130.49 | 37.2K | Nov 5, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -2K | -4.5% | $0.00 | 42.4K | Nov 5, 2021 | Common | 2K | $63.55 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. |
F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
F3 | The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023. |